Search

Your search keyword '"Niyamat Ali Siddiqui"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Niyamat Ali Siddiqui" Remove constraint Author: "Niyamat Ali Siddiqui" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
40 results on '"Niyamat Ali Siddiqui"'

Search Results

1. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.

2. Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysis

3. Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis

4. Suicidal ideation associated with vitiligo - A systematic review of prevalence and assessment

5. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.

6. Early diagnostic marker for the conversion of asymptomatic to symptomatic visceral leishmaniasis

7. Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis

8. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.

9. Advanced case of PKDL due to delayed treatment: A rare case report.

10. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis

11. Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India.

12. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).

13. Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.

15. Association between diet quality scores, adiposity, glycemic status and nutritional biomarkers among Indian population with type 2 diabetes mellitus: A cross-sectional study

16. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India

17. Viral Etiological Factors Causing Acute Encephalitis Syndrome (AES) In Gaya Division, India

18. The usefulness of trained field workers in diagnosis of post-kala-azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar

19. A co-infection with malaria and visceral leishmaniasis in Eastern state of India

20. Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme

21. False Positivity of rK39 Test in Five Chronic Myeloid Leukemia Cases from Bihar, India: A Possible Challenge to Leishmaniasis Diagnosis

22. Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India

23. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis

24. Investigating Associative Impact of Indoor Residual Spray and Insecticide Treated Nets for Minimizing Visceral Leishmaniasis Vector Population in Bihar (India)

25. Noninvasive Sweat-Based Diagnosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

26. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers

27. A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis

28. Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis

29. Self-healing and Underreporting of Cases of Visceral Leishmaniasis in Bihar, India: A Mathematical Modeling-based Study

30. Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India

31. Spatial clustering of Plasmodium falciparum in Bihar (India) from 2007 to 2015

32. Advanced case of PKDL due to delayed treatment: A rare case report

33. Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis

34. Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India

35. Longitudinal study of transmission in households with visceral leishmaniasis, asymptomatic infections and PKDL in highly endemic villages in Bihar, India

36. Early diagnostic marker for the conversion of asymptomatic to symptomatic visceral leishmaniasis

37. Community-based Detection of Post Kala-azar Dermal Leishmaniasis (PKDL) and its Risk-Factors in an Endemic Region of Bihar, India

38. Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India

39. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)

40. Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison

Catalog

Books, media, physical & digital resources